Sign in
4

Changes in Ownership

Monte Rosa Therapeutics, Inc. Filed Acc 0000950170-25-002100

President & CEO acquired 128,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Warmuth Markus President & CEO 2025-01-02 Grant or award +128,000 544,538 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Warmuth Markus President & CEO 2025-01-02 Grant or award · Stock Option (Right to Buy) +575,000 575,000 D: show line 2 in the form
Loading xslF345X05/ownership.xml…